Xenon Pharmaceuticals Inc.
XENE · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $3,053,470 | $3,080,907 | $2,387,177 | $1,362,922 |
| - Cash | $142,712 | $148,643 | $57,242 | $175,688 |
| + Debt | $9,015 | $10,903 | $10,435 | $8,257 |
| Enterprise Value | $2,919,773 | $2,943,167 | $2,340,370 | $1,195,491 |
| Revenue | $0 | $0 | $9,434 | $18,437 |
| % Growth | – | -100% | -48.8% | – |
| Gross Profit | -$2,560 | -$167,512 | $9,434 | $18,437 |
| % Margin | – | – | 100% | 100% |
| EBITDA | -$235,859 | -$210,513 | -$127,738 | -$78,087 |
| % Margin | – | – | -1,354% | -423.5% |
| Net Income | -$234,330 | -$182,393 | -$125,373 | -$78,882 |
| % Margin | – | – | -1,328.9% | -427.8% |
| EPS Diluted | -3.01 | -2.73 | -2.06 | -1.77 |
| % Growth | -10.3% | -32.5% | -16.4% | – |
| Operating Cash Flow | -$181,389 | -$145,327 | -$98,430 | -$69,502 |
| Capital Expenditures | -$3,075 | -$5,617 | -$2,894 | -$2,050 |
| Free Cash Flow | -$184,464 | -$150,944 | -$101,324 | -$71,552 |